SBI Securities »

Lineage Cell Therapeutics In shares owned by SBI Securities

Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by SBI Securities from 13F filings

Historical chart of SBI Securities investment in Lineage Cell Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including Lineage Cell Therapeutics In held by SBI Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lineage Cell Therapeutics In by SBI Securities

Quarter filed Position value Share count Share price at filing
2025-09-30 $13k 7.9k 1.69
2025-06-30 $7.5k 8.3k 0.91
2025-03-31 $3.9k 8.6k 0.45
2024-12-31 $3.4k 6.7k 0.50

More positions owned by SBI Securities

NVIDIA Corporation (NVDA)
Vanguard S&P 500 ETF Etf (VOO)
Vanguard Total Stock Market ETF Etf (VTI)
Tesla Motors (TSLA)
Apple (AAPL)
Invesco QQQ Trust Series 1 ETF Etf (QQQ)
Palantir Technologies (PLTR)
Microsoft Corporation (MSFT)
Vanguard Total World Stock ETF Etf (VT)
Amazon (AMZN)
Vanguard High Dividend Yield ETF Etf (VYM)
Alphabet Inc Class A cs (GOOGL)
SPDR Portfolio S&P500 HighDividend ETF Etf (SPYD)
Facebook Inc cl a (META)
Direxion Daily Semi Bull 3X Etf (SOXL)

View all positions for SBI Securities

Top funds holding Lineage Cell Therapeutics In

Broadwood Capital
Vanguard Group
Raffles Associates
Brian McDonald
Millennium Management
Geode Capital Management
BlackRock
Renaissance Technologies
Dauntless Investment Group
State Street Corporation
Morgan Stanley
GSA Capital Partners
Red Crane Wealth Management
Northern Trust
Eudaimonia Asset Management

View all funds holding Lineage Cell Therapeutics In